Live·Open questions in longevity research
All news
Science ResearchTherapeutics

Mice given a single dose of mRNA to trigger heart muscle cell division after a heart attack lost less pumping function than controls; a different method that triggered division throughout the heart killed seven of eight mice

12 November 2026· 261112008

Mice given a single dose of mRNA to trigger heart muscle cell division after a heart attack lost less pumping function than controls; a different method that triggered division throughout the heart killed seven of eight mice

A study by researchers at the University of Cambridge, QIMR Berghofer and AstraZeneca was published on 9 November in Nature Cardiovascular Research. The researchers injected modified mRNA into the ventricular wall of mice. This mRNA provides instructions for cells to produce Myc and cyclin T1, proteins that trigger cell division. Five authors are AstraZeneca employees, and two are named inventors on a patent related to the work.

According to the University of Cambridge, an adult human heart can lose up to a billion heart muscle cells, or cardiomyocytes, during a heart attack. The heart weakens, and scar tissue may replace the dead cells. Bryan Williams of the British Heart Foundation says that “shortly after birth, our heart muscle cells lose their ability to regenerate and repair the heart.”

A 2020 study found that Myc activates genes involved in growth and division, but has little effect in the adult mouse heart because a supporting protein complex is in short supply. Cyclin T1 determines how much of this complex is available. When cyclin T1 was added alongside Myc, cardiomyocytes began to divide.

The researchers tested this pair in injured hearts. Before inducing a heart attack, they gave mice a virus carrying the cyclin T1 gene. The mice also had Myc engineered into their genome so that tamoxifen could activate it in all cardiomyocytes. After the heart attack, Myc was activated for two days. Near the injury, the Ki67 marker indicated that 25,1% of cardiomyocytes had entered the cell cycle, compared with 0,2% in controls. However, within 3–7 days of activation, seven of eight mice died or were euthanized, compared with none of the controls. The authors suggest that because cells dismantle their contractile apparatus before dividing, a heart in which this happens throughout the muscle may be at risk of arrhythmia.

To restrict the area affected, the researchers activated Myc for the same two days only near the injury. They injected mRNA encoding the Cre enzyme into the ventricular wall; the engineered Myc remains inactive without Cre. Myc was activated in 9–10% of the left ventricle, and the mice survived. By day 28, ejection fraction, the proportion of blood the ventricle pumps out with each contraction, had fallen by 9 percentage points, compared with 23 in controls. The scar was smaller, and there was more muscle tissue.

The researchers then developed a prototype treatment: a single mRNA of the same type used in coronavirus vaccines, carrying instructions for both Myc and cyclin T1. They injected it during surgery immediately after the heart attack. Both proteins were detected in the heart after 1 and 4 hours, but neither was detected after a day. A reporter protein produced from control mRNA persisted for at least 48 hours, whereas Myc itself has a half-life of 20–40 minutes. The authors aimed for a “physiologically normal” pulse: in species capable of regeneration, Myc activity rises briefly after injury.

By day 28, ejection fraction had fallen by 26 percentage points, compared with 37 in controls, and the difference persisted for 12 weeks. Scar size did not differ from that in controls, but there was more muscle tissue, with no change in cell size. This could reflect better cell survival or cell division. Signs of cell death 4 hours after the heart attack were unchanged. Because Ki67 marks cells at any phase of the cell cycle, the authors also used a permanent label to identify cells that had reached division. Among labeled cardiomyocytes, 41,5% occurred in pairs resembling daughter cells, compared with 5,5% after control mRNA. The authors attribute the benefit to cell division.

An experiment by coauthor Mauro Giacca (2019) showed the consequences of a prolonged signal. In pigs, a virus carrying the gene for microRNA-199a, which triggers cardiomyocyte division, reduced scar size. Its continued activity subsequently led to sudden arrhythmic death in most of the animals. For use in humans, the authors propose delivering the mRNA in lipid nanoparticles through a catheter.

Originally published on Telegram by Ukhvat NewsView on Telegram
Sources
#mrna#heart-regeneration#cardiomyocytes#myc#cyclin-t1#heart-attack